UPSA
↗Agen, France
UPSA is a French pharmaceutical company founded in 1935 and headquartered in Agen (Lot-et-Garonne), France. It is one of Europe's largest pharmaceutical manufacturing sites, producing over-the-counter medicines, dietary supplements, and medical devices. UPSA specializes in self-medication products across pain relief, respiratory, digestive, sleep, and women's health therapeutic areas. The company is now a subsidiary of Taisho Pharmaceutical Holdings Co., Ltd. (acquired from Bristol Myers Squibb in July 2019 for $1.6 billion). UPSA serves patients across more than 60 countries and is the leading manufacturer of paracetamol-based medicines in France. The company became the first pharmaceutical laboratory in France to be certified 'Origine France Garantie' (ensuring 100% manufacturing in France) and achieved B Corporation certification in 2024.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Over-the-Counter (OTC) Consumer Health, Dietary Supplements, Medical Devices
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$€300M-€1B (targeting €1B by 2027)
Founded:1935
Ownership:subsidiary
Status:operating
FUNDING
Investors:Taisho Pharmaceutical Holdings Co., Ltd.
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Dafalgan, Efferalgan, Fervex)
Modalities:Small molecule, Dietary supplements, Medical devices
Active Trials:1
Trial Phases:Phase 4: 1
CORPORATE STRUCTURE
Parent Company:Taisho Pharmaceutical Holdings Co., Ltd.
Acquired By:Taisho Pharmaceutical Holdings Co., Ltd. (2019-07-01)
Subsidiaries:UPSA Belgium, UPSA Switzerland, UPSA Italy, UPSA Spain, UPSA United Kingdom, UPSA China
Key Partnerships:Sérélys Pharma (acquired 2024 - women's health expansion), SWIXX BioPharma (Russia distribution agreement 2020)
COMPETITION
Position:Leader
Competitors:Sanofi, GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser, Perrigo, Church & Dwight, Procter & Gamble (OTC division)
LEADERSHIP
Key Executives:
Isabelle Van Rycke - President and Chief Executive Officer
Patrick M. Leimgruber - General Manager
Scientific Founders:Dr. Camille Bru (founder, 1935) - developed effervescent digestion solution Normogastryl®
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with UPSA. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.